This website uses cookies for anonymised analytics and for core features such as voting on polls and comments. See our privacy and cookies policies for more information.




The voice of Scotland’s vibrant voluntary sector

Published by Scottish Council for Voluntary Organisations

TFN is published by the Scottish Council for Voluntary Organisations, Mansfield Traquair Centre, 15 Mansfield Place, Edinburgh, EH3 6BB. The Scottish Council for Voluntary Organisations (SCVO) is a Scottish Charitable Incorporated Organisation. Registration number SC003558.

Funding for cancer put on hold as covid cancels treatment

This news post is about 1 year old
 

Without research the fight against cancer can't be won

Cancer Research UK fears the £40m income it has lost could treble if the UK government doesn’t step in to help.

Following the cancellation of fundraising events such as Race for Life, Cancer Research UK is expecting a £160m drop in income in the year ahead – meaning a £44m cut to research funding.

The charity’s public affairs manager in Scotland, Kirsty Slack, said: “We’ve taken the decision to prioritise funding for our existing trials, but that cut in income might impact our ability to fund as many trials in the future.

“So we’re really concerned about what this means for progress.”

It comes as a survey found that 40% of charity-funded early career researchers have considered leaving the field due to the cuts.

First-year PHD student Mahnoor Mahmood is studying how DNA mutations in the powerhouses’ in our cells – structures called mitochondria – can cause cancer.

She said: “If I had been applying this year I don’t even think this position would have been available.

“We are quite a new group, I don’t think our group would have existed in the first place. It is something that is nagging me at the back of my head – what will happen in four years’ time or will I need an extension if I need to stay longer?”

Mum-of-two Lori Delaney was diagnosed with grade-three breast cancer. Her treatment had to be changed and condensed when the pandemic hit.

She is now on the drug tamoxifen for the next 10 years.

Lori said: “A drug which wouldn’t exist if it wasn’t for Cancer Research UK. It’s not a lovely drug to be on, but better than the alternative.”

She added: “For a lot of people that wouldn’t mean anything, but when you’ve been in the middle of it, it does because you know how safe that makes you feel, the amount of research that is behind that.”

 

Comments

Be the first to comment.